Company profile
Danaher Corporation
NYSE: DHR · Healthcare · Medical - Diagnostics & Research
#24 of 1,418 Healthcare companies by revenue46th-percentile growth
EA Score
87AFH 88DQ 99GM 54SS 99
v0.1 · 65/100 weight · provisional
↑ filing timeliness, market scale · ↓ growth stability, revenue growth (YoY)
Methodology →Revenue TTM
$24.8B
Rev growth YoY (TTM)
+4.0%
Net income (FY)
$3.6B
Employees
59,000
as of 2026-09-04
Market cap
$148.3B
as of 2026-09-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$24.6B$24.6B2025
Net income$3.6B$3.6B2025
Operating income$4.7B$4.7B2025
Total assets$83.5B$83.5B2025
Liabilities$8.4B$8.4B2010
Equity$52.5B$52.5B2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY22
FY23
FY23
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Revenue from Contract with Customer, Measurement, Recurring82%
Revenue from Contract with Customer, Measurement, Nonrecurring18%
By geography
Other developed markets82%
CHINA18%
The read
What is Danaher Corporation’s revenue?
Danaher Corporation booked $24.6B in FY2025 revenue, growing 2.9% year over year — about the middle of the pack among Healthcare companies we track, at a 14.7% net margin.
Peers · Healthcare
Gilead Sciences, Inc.87AMedline Inc.62CStryker Corporation87ABecton, Dickinson and Company83B+Tenet Healthcare Corporation78B+GE HealthCare Technologies Inc.69BNeighbors
District of Columbia →Key facts
CEORainer Blair
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersWashington, DC
ExchangeNYSE: DHR
Employees59,000
IPO date1978-12-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.